5034
M.-J. Chen et al. / Tetrahedron 56 (2000) 5029±5035
34.9; HRMS: Calcd for C18H17SO3N: 327.0929; found:
327.0929.
1H NMR(400 MHz, CDCl3, 2408C): anti-form d 7.12±7.37
(5H, m), 6.64 (1H,dd, J17.1, 10.8 Hz), 5.60 (5H, s), 5.32
(1H, dd, J8.3, 7.5 Hz), 5.10 (1H, d, J10.8 Hz), 5.01(1H,
d, J17.1 Hz), 3.39 (1H, m, J8.3 Hz), 2.88 (3H, s), 2.44
(1H, d, J7.5 Hz), syn-form 7.12±7.37 (5H, m), 6.40 (1H,
dd, J17.4, 10.7 Hz), 5.68 (5H, s), 5.32 (1H, overlapped
with that of anti isomer), 5.07 (2H, m), 3.18 (1H, m), 2.80
(3H, s), 2.63 (1H, m); 13C NMR (100 MHz, CDCl3, 2208C):
d 228.3, 215.6, 149.1, 142.8, 128.3, 126.9, 125.4, 135.6,
128.4, 114.7, 92.8, 64.5, 39.8, 25.7; MS (EI, m/e): 581
(M1). Anal Calcd for WC21H19SO5N: C, 43.39; H, 3.29;
N, 2.41; found C: 43.23; H, 3.55; N, 2.20.
1-Mesyl-3-ethylidene-5-phenyl-g-lactam (8). This com-
pound was prepared according to the procedure for the
synthesis of 5; the yield was 59%. IR (neat, cm21): n(CO)
1719(vs), n(CvC) 1655(m), n(SO2) 1354(s); 1H NMR
(300 MHz, CDCl3): d 7.22±7.37 (5H, m, Ph), 6.89 (1H,
m), 5.28 (1H, dd, J9.2, 1.8 Hz), 3.20 (1H, m, J16.0,
9.2 Hz), 2.91 (3H, s), 2.71 (1H, dd, J16.0, 1.8 Hz), 1.81
(3H, d, J2.6 Hz); 13C NMR (75 MHz, CDCl3): d 166.9,
141.2, 135.5, 129.6, 125.9, 129.1, 128.4, 59.2, 41.4, 32.3,
15.1. HRMS: Calcd for C13H15SO3N, 265.0784; found
265.0772.
1-Tosyl-3-vinyl-5-phenyl-4,5-dihydropyrrole (13). To a
CH3CN solution of compound 11 (0.33 g, 0.50 mmol) was
added Me3NO (75 mg, 1.00 mmol), and the mixtures were
stirred for 6 h. The solution was concentrated and eluted
through a preparative silica plate to afford compound 13
as a colorless oil (74 mg, 0.23 mmol, 46%). IR(neat,
cm21): n(CvC) 1638(m), n(SO2) 1341(s); 1H NMR
(300 MHz, CDCl3): d 7.18±7.58 (9H, m, 2 Ph), 6.58 (1H,
s), 6.46 (1H, dd, J17.3, 10.6 Hz), 4.97 (1H, d, J10.7 Hz),
4.80±4.84 (2H, m), 3.04 (1H, m, J15.9, 9.2 Hz), 2.54
(1H, dd, J15.9, 6.4 Hz), 2.39 (3H, s); 13C NMR
(75 MHz, CDCl3): d 143.8, 142.3, 129.7, 129.4, 128.9,
128.6, 128.4, 127.6, 126.4, 126.4, 113.4, 63.6, 39.5,
21.6; HRMS: Calcd for C19H19SO2N, 325.1136; found
325.1142.
1-(But-3-enoyl)-3-(phenylethenyl)-g-lactam (9). This
compound was prepared according to the procedure for
the synthesis of 5; the yield was 72%. IR (neat, cm21):
1
1750(s), 1711(s), 1647(m); H NMR (CDCl3, 400 MHz):
d 7.31 (5H, m), 6.53 (1H, dd, J16.0, 1.6 Hz), 6.25 (1H,
dd, J16.0, 6.4 Hz), 5.85 (1H, m), 5.06 (1H, dd, J10.4,
3.6 Hz), 4.99 (1H, dd, J10.4, 2.8 Hz), 3.95 (1H, m), 3.65
(1H, m), 3.47 (1H, m), 3.03 (2H, t, J7.2 Hz), 2.37 (3H, m),
2.02 (1H, m); 13C NMR (100 MHz, CDCl3): 175.1, 173.7,
137.0, 136.4, 133.2, 128.6, 127.8, 126.4, 124.8, 115.4, 47.7,
43.4, 36.2, 28.1, 24.4. HRMS Calcd for C17H18NO2:
269.1416, found: 269.1418.
1-(But-3-enoyl)-3-(ethylidene)-g-lactam (10). This com-
pound was prepared according to the procedure for the
synthesis of 5; the yield was 71%. IR (neat, cm21):
1-Mesyl-3-vinyl-5-phenyl-4,5-dihydropyrrole (14). This
compound was prepared according to the procedure for
synthesis of compound 13. IR (neat, cm21): n(CvC)
1638(m), n(SO2) 1341(s); 1H NMR (400 MHz, CDCl3,
2408C): anti-form, d 7.12±7.37 (5H, m) 6.64 (1H, dd,
J17.1 Hz, 10.8 Hz), 5.60 (5H, s), 5.32 (1H, dd, J8.3,
7.5 Hz), 5.10 (1H, d, J10.8 Hz), 5.01 (1H, d, J
17.1 Hz), 3.39 (1H, m, J8.3 Hz), 2.88 (3H, s) 2.44 (1H,
m, J7.5 Hz), syn-form, 7.12±7.37 (5H, m), 6.40 (1H, dd,
J17.4, 10.7 Hz), 5.68 (5H, s), 5.32 (1H, dd, J8.3,
7.5 Hz), 5.07 (2H, m), 3.18 (1H, m), 2.80 (3H, s), 2.63
(1H, m); 13C NMR (100 MHz, CDCl3, 2208C): d 228.3,
215.6, 149.1, 142.8, 128.3, 126.9, 125.4, 135.6, 128.4,
114.7, 92.8, 64.5, 39.8, 25.7; MS (EI, m/z): 581 (M1).
Anal. Calcd for WC21H19SO5N: C, 43.39; H, 3.29; N,
2.41; found C, 43.23; H, 3.55; N, 2.24.
1
1750(s), 1711(s), 1647(m); H NMR (CDCl3, 400 MHz):
d 6.76 (dq, J7.6, 2.4 Hz), 5.86 (1H, m), 5.06 (1H, ddd,
J9.6, 2.4, 1.6 Hz), 4.97 (1H, dd, J9.6, 2.4 Hz), 3.78 (1H,
t, J7.6 Hz), 3.07 (2H, t, J7.6 Hz), 2.65 (2H, m), 2.40
(2H, m), 1.82 (3H, dt, J7.6, 2.4 Hz); 13C NMR
(100 MHz, CDCl3): 174.3, 167.7, 137.2, 134.1, 132.6,
115.3, 42.0, 36.2, 28.2, 20.3, 15.0. HRMS: Calcd for
C11H15NO2: 193.1103; found: 193.1095.
CpW(CO)3(h1-1-tosyl-3-vinyl-5-phenyl-4,5-dihydropyrrol-
2-yl) (11). To a CH2Cl2 solution of azacyclic carbenium salt
2
(0.30 g, 0.40 mmol) was added Et3N (0.081 mL,
0.80 mmol) at 08C, and the mixtures were stirred for 1 h.
The residues were chromatographed through a short
alumina column to give a yellow band to afford 11 as a
yellow solid (0.23 g, 0.36 mmol, 89%). IR (neat, cm21):
n(CO) 2025(vs) 1922(s), n(SO2) 1332(s); 1H NMR
(400 MHz, CDCl3, 2408C): anti-form d 7.04±7.40 (9H,
m, 2 Ph), 6.50 (1H, dd, J17.0, 10.8 Hz), 5.58 (5H, s),
5.30 (1H, dd, J8.3, 7.5 Hz), 5.14 (1H, d, J10.8 Hz),
5.01 (1H, d, J17.1 Hz), 3.30 (1H, m, J8.3 Hz), 2.87
(3H, s), 2.51 (1H, d, J7.5 Hz), syn-form 7.12±7.47 (5H,
m), 6.43 (1H, dd, J17.4, 10.7 Hz), 5.69 (5H, s), 5.30 (1H,
overlapped with that of anti isomer), 5.08 (2H, m), 3.16 (1H,
m), 2.82 (3H, s), 2.69 (1H, m); MS (EI, m/e): 657. Anal.
Calcd for C27H23WNSO5: C, 49.31; H, 3.53; Found: C,
49.04; H, 3.66.
1-(Methylsulfonyl)-2-phenyl-2,3,5,5a,6,8,8a,8b-octahydro-
1H-furo[3,4-g]indole-6,8-dione (15). To a d8-toluene
solution (1.0 mL) of diene 14 (30 mg, 0.12 mmol) was
added maleic anhydride (13 mg, 0.132 mmol) in a sealed
NMR tube, and the NMR sample was heated at 608C for
2 h. NMR spectra of this solution showed the completion of
reaction. The solution was concentrated and eluted through
a preparative silica TLC-plate to afford compound 14 as a
colorless solid (38 mg, 0.11 mmol, 92%). IR (neat, cm21):
1
n(CvO) 1767(vs); H NMR (400 MHz, CDCl3): d 7.30
(5H, m), 5.84 (1H, m), 5.04 (1H, dd, J8.0, 3.6 Hz), 4.31
(2H, t, J6.4 Hz), 3.37 (1H, m), 3.06 (1H, dd, J17.2,
8.0 Hz), 2.78 (2H, m), 2.38 (3H, s), 2.34 (1H, m); 13C
NMR (100 MHz, CDCl3): d 173.8, 170.0, 143.2, 140.6,
128.9, 128.7, 127.7, 118.3, 64.9, 59.3, 45.1, 40.8, 39.9,
38.2, 25.9. HRMS: Calcd for C17H17NO5S, 347.0827;
found 347.0831.
CpW(CO)3(h1-1-mesyl-3-vinyl-5-phenyl-4,5-dihydropyrrol-
2-yl) (12). This compound was prepared according to the
procedure for synthesis of compound 11; the yield was 91%.
IR (neat, cm21): n(CO) 2025(vs), 1922(s); n(SO2) 1332(s);